Matt Gethers/20.380 HIV Project/Technical Paper/Jessie InVivo
From OpenWetWare
Jump to navigationJump to search
Jessie: In Vivo and Clinical Studies
Introduction/Definitions
- Purpose of In Vivo Studies/Animal Models
- Purpose of Pre-clinical studies
- Brief history of clinical trials
Proof of Concept - In Vivo Studies
- Animal Model: Most likely macaque
- Can use pig-tailed macaque with the stHIV that has a 95% similarity to HIV-1, but infection only lasts a couple months and does not progress to AIDS
- Can be used to test prophylactic effect
- Can use macaque model with SIVmac that will allow macaque to develop SAIDS
- Are SIV and HIV similar enough for this to be a proof of concept?
- Can use pig-tailed macaque with the stHIV that has a 95% similarity to HIV-1, but infection only lasts a couple months and does not progress to AIDS
- Things to look at:
- Varying doses of HSCs - what is the optimal/plausible number of engineered HSCs needed?
Pre-clinical Studies
- Biggest concern is safety
- Can engineered HSCs become cancerous? - Drug super-sensitivity will be helpful
- What other safety concerns are there with regards to stem cell therapies?
- Need to prove natural functionality of engineered HSCs
- Differentiate properly
- RBCs function properly
- What else do we need to prove before getting FDA approval?
Clinical Studies
- Phase I
- Prove mainly safety of treatment in humans
- Should we do similar to Koronis and divide into Ia and Ib where Ia is in healthy volunteers and Ib is in people who have failed other HIV treatments?
- Where should we conduct our trial? US or Africa?
- Phase II
- Phase III